Literature DB >> 1674091

Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus.

F Nicoletti, P L Meroni, M Lunetta, R Vigo, T Palermo, D Papalia, W Barcellini, M Di Mauro, M Caruso-Nicoletti, L Mughini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1674091     DOI： 10.1016/0140-6736(91)92964-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial.

Authors:  I Conget; E Aguilera; S Pellitero; S Näf; K Bendtzen; R Casamitjana; R Gomis; F Nicoletti
Journal:  Diabetologia       Date:  2005-07-02       Impact factor: 10.122

2.  Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock.

Authors:  F Genovese; G Mancuso; M Cuzzola; V Cusumano; F Nicoletti; K Bendtzen; G Teti
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

3.  Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.

Authors:  F Nicoletti; P Zaccone; R Di Marco; G Magro; S Grasso; S Morrone; A Santoni; G Tempera; P L Meroni; K Bendtzen
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

4.  Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma.

Authors:  F Nicoletti; R Di Marco; S Morrone; P Zaccone; D Lembo; S Grasso; A Santoni; P L Meroni; K Bendtzen
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.